Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Scientific Officer

President and CEO

Chief Operating Officer

Chief Medical Officer

Chief Legal Officer

Chief Financial Officer

SVP Reg. & Quality

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.

Cerus Corporation operates as a biomedical products company.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-14	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-03-14	Premium	sold	Premium	Premium	Premium	President and CEO
2024-03-14	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-03-14	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-03-14	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2024-03-14	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-03-13	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-03-13	Premium	sold	Premium	Premium	Premium	President and CEO
2024-03-13	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-03-13	Premium	sold	Premium	Premium	Premium	SVP Reg. & Quality
2024-03-13	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-03-13	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2024-03-13	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-03-12	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2024-03-12	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-03-12	Premium	acquired	Premium	Premium	Premium	SVP Reg. & Quality
2024-03-12	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-03-12	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-03-12	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2024-03-12	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-03-08	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	SVP Reg. & Quality
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer

CERS - Cerus Corp Stock Price, Fair Value and News

Latest Insider Trading transactions for CERS